A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa
Philip E. LeBoitiD, D. U. PateliD, Jarish N. CoheniD, Madison I. MossiD, Haley Bharat NaikiD, Ashley E. YatesiD, Hobart W. HarrisiD, Daniel M. KlufasiD, Esther A. KimiD, Isaac M. NeuhausiD, Scott L. HanseniD, Ryan L. KyleiD, M. KellyiD, Michael D. RosenblumiD, Margaret M. LoweiD
Abstract
Hidradenitis Suppurativa (HS) is a relatively common and highly morbid inflammatory skin disease. Due to our relatively limited understanding of HSs pathogenesis, there are currently insufficient treatment options available, and many patients medical needs are not being met. This is partly due to a scarcity of ex vivo human assays and animal models that accurately recapitulate the disease. To address this deficit, we have developed a whole-tissue explant model of HS to examine its pathogenic mechanisms and the efficacy of potential treatments within intact human tissue. We measured cytokine protein and RNA within whole tissue maintained in an agar-media solution, finding that IL-6 and IL-8 concentrations trended upwards in both HS explants and healthy controls, while IL-17A, IL-1{beta}, and TNF- exhibited increases in HS tissue alone. We also show that the explants were responsive to treatment with both dexamethasone and IL-2. Not only do our results show that this model effectively delivers treatments throughout the explants, but they also elucidate which cytokines are related to the explant process regardless of tissue state and which are related to HS tissue specifically, laying the groundwork for future implementations of this model.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 3.30
- Field percentile
- top 10%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ex Vivo Culture Models of Hidradenitis Suppurativa for defining molecular pathogenesis and treatment efficacy of novel drugs
K. Goliwas, M. P. Kashyap, … M. Athar·bioRxiv·Oct 11, 2021
- Human Dermal Fibroblast Subpopulations and Epithelial Mesenchymal Transition Signals in Hidradenitis Suppurativa Tunnels are Normalized by Spleen Tyrosine Kinase Antagonism in Vivo
A. Flora, R. Jepsen, … J. W. Frew·bioRxiv·Feb 23, 2023
- Pathogenic Keratinocyte States and Fibroblast Niches Define the Tissue Microenvironment in Severe Hidradenitis Suppurativa
Xinyi Du-Harpur, Clarisse Gânier, … Fiona M. Watt·bioRxiv·Nov 11, 2025
- Defining Epidermal Stem Cell Fate Infidelity and Immunogenicity in Hidradenitis Suppurativa at the Single-Cell Resolution
M. Marohn, M.-j. Lin, … C. P.-J. Lu·bioRxiv·Apr 21, 2020
- NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2
Mahendra Pratap Kashyap, Bharat Mishra, … Chander Raman·bioRxiv·Oct 31, 2023
- Mass cytometry identifies dysregulation of circulating and cutaneous immune cells in patients with hidradenitis suppurativa
P. Dimitrion, I. Hamzavi, … Q.-S. Mi·bioRxiv·Jan 27, 2023